Lisa P van der Rijst

9PUBLICATIONS
21CO-AUTHORS
AllergyAdolescent healthInfant and child healthSocial program evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 01, 2025
Current treatment landscape of atopic dermatitis focusing on real-world evidence of dupilumab treatment.

Celeste M Boesjes, Lian F van der Gang, Roselie E Achten

|Jul 31, 2025
Upadacitinib in daily practice for refractory atopic dermatitis in adolescents: a case series of the BioDay registry.

Florence Vroman, Lisa P van der Rijst, Octavian I Bacoş-Cosma

|May 16, 2025
Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and Serum.

Lisa P van der Rijst, Edward F Knol, Nicolaas P A Zuithoff

|Feb 05, 2025
Ocular surface disease in pediatric patients with moderate-to-severe atopic dermatitis.

Lisa P van der Rijst, Nienke Veldhuis, Sara van der Kamp

|Aug 19, 2024
Reply to Sujoy Khan.

Lisa P van der Rijst, Karin M de Winter-de Groot, Marjolein S de Bruin-Weller

|Jul 17, 2024
Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patients.

Lisa P van der Rijst, Michelle S Hilbrands, Nicolaas P A Zuithoff

Pageof 2